Healthcare Professional Resources

Resources to Support Neuroendocrine Cancer Care

Access trusted, evidence-based materials to support the diagnosis, treatment, and management of neuroendocrine cancer in clinical practice.

Alternatively, you can order printed resources here.

Filter by:
Or browse by popular tag:
Educational Videos

NETs Under the Microscope – Webinar

Advocacy & Awareness Videos

NeuroEndocrine Cancer Australia Thankyou Video

HCP Videos

Neuroendocrine Cancer Symptoms: Full Interview with Dr David Chan

HCP Videos

Neuroendocrine Cancer Symptoms: Full Interview with Dr John Leyden

HCP Videos

Neuroendocrine Cancer Symptoms: Full Interview with Prof Nick Pavlakis

HCP Videos

Neuroendocrine Cancer Symptoms: Specialist interview: Dr Bill Macdonald and Dr David Ransom

HCP Videos

Neuroendocrine Cancer Symptoms: With Dr Gabrielle Cehic AM

HCP Videos

Neuroendocrine Cancer Symptoms: With Meredith Cummins

Courses

Neuroendocrine Tumour Education Course

Booklets & Guides

Neuroendocrine tumours: A guide for healthcare professionals

Clinical Trials

ONJCRI Immunotherapy Trial: Nivolumab & Ipilimumab for Rare and Advanced Cancers

This protocol provides an important opportunity to establish whether the combination of nivolumab & ipilimumab has efficacy in these cancers.
Educational Videos

Optimal Care Pathway for Neuroendocrine Tumours (NETs)

Clinical Trials

PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours (PARLuNET)

PARLuNET is a phase 1 dose-escalation study designed to evaluate the safety and tolerability of talazoparib (PARP Inhibitor) in...
Other Resources

Patient Card – Medical Alert

Clinical Trials

Phase 3 Trial of CAM2029 vs Standard Treatments in GEP-NET Patients

The purpose of this study is to compare the effectiveness and safety of CAM2029 to octreotide LAR or lanreotide ATG in patients with advanced, well-differentiated GEP-NET.
Fact Sheets

Quick Facts

Walk, run, or ride this March4NETs!

For its third year, March4NETs will run throughout March 2026.

Get involved and support the 31,000 Australians living with neuroendocrine cancer.